NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

AMAG Pharmaceuticals Inc., a specialty drug company, said it will acquire Cord Blood Registry for $700 million to expand its maternal health business. CBR houses more than 600,000 preserved umbilical cord blood and tissue stem cell units, more than half of all privately stored cord units in the U.S., Waltham,…

news

Marksans Pharma shares rose over 9 per cent to touch an intraday high of Rs 64.40 on Tuesday after the company said that it has acquired US-based Time-Cap Laboratories for an undisclosed amount.. The acquisition was done through its wholly-owned subsidiary, Marksans Pharma. With this move, the company is strategically…

news

The U.S. Food and Drug Administration was sued by two advocacy groups seeking to force the faster disclosure of clinical trial data that helped Gilead Sciences Inc win approval for two blockbuster hepatitis C drugs. In their June 25 lawsuit, Yale University's Global Health Justice Partnership and the Treatment Action…

news

Dr Reddy's Laboratories has initiated a voluntary recall of some drugs used to treat seizure and hypertension from the US market. The firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests, and Amlodipine Besylate and Atorvastatin Calcium tablets since these are close to expiry time.…

news

The government plans to set up a Rs 500-crore venture capital fund to boost the domestic pharmaceutical industry and provide cheaper loans to entities looking to establish or upgrade manufacturing facilities. The government is working on various proposals, including single window clearance for drug approvals, to rejuvenate the local pharma…

news

Pharma major Lupin is looking at strengthening its branded portfolio by creating alliances and eyeing strategic brand acquisitions in US markets in 2015-16. The United States is Lupin's largest market and contributed 45 per cent of the company's revenues in 2014-15. "In 2015-16, the company remains committed to continuing to…

news

New drugs from Novartis and Alexion won a green light from European regulators on Friday, delivering a boost to both drugmakers and offering new treatment options for cancer and rare diseases. Experts from the European Medicines Agency (EMA) said they had recommended approval of Novartis's Farydak for multiple myeloma, an…

news

Zhejiang Jiuzhou Pharmaceutical Co Ltd Says to acquire 80 percent stake in a pharma firm for 124.95 million yuan ($20.13 million) and boost capital by 100 million yuan.   reuters.com

news

Siemens, a global technology powerhouse,  and BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, have entered into a strategic collaboration. BioNTech AG's subsidiaries, BioNTech RNA Pharmaceuticals GmbH and EUFETS GmbH, will work together with Siemens on the construction of a fully automated and digitalized production site…

news

Plans to create a £10bn ‘megafund’ that would make it easier for pharmaceutical companies in London and across the country to develop groundbreaking new drugs and treatments is one of a number of options that will be discussed today at a special conference hosted by the Mayor of London’s Office.…